SCHEMBL5163832

SCHEMBL5163832

CCCC(=O)OC(=O)N(CCc1ccccc1)C(=O)NCc1ccc(N(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
ALOX15 P16050 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
MCL1 Q07820 1/20 0.41
KDM4E B2RXH2 4/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
POLB P06746 1/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160351 0.82 EPHX2 (0.46) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL5160138 0.79 ALDH1A1 (0.44) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL5158167 0.78 ALDH1A1 (0.46) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL5159890 0.74 ALDH1A1 (0.41) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL29221815 0.69 KMT2A (0.61) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL15559955 0.67 MEN1 (0.48) MAPTMAPK1KDM4EPOLBHDAC1
SCHEMBL23069543 0.67 TDP1 (0.61) ALDH1A1NPC1MAPTRAB9AKDM4E
SCHEMBL5162886 0.66 ALDH1A1 (0.60) ALDH1A1ALOX15SMN1; SMN2NPC1MAPT
SCHEMBL30503476 0.66 CTSK (0.43) NPC1MAPTRAB9AGAAPOLB
SCHEMBL29079457 0.65 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753733-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES Avanir Pharmaceuticals (US) 2007-02-21 EP disclosed
WO-2005123700-A1 SMALL MOLECULES FOR TREATMENT OF HYPERCHOLESTEROLEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed